SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individualsKaori Sano, Florian Krammer, Wanni A. Mendez et al.|Nature Communications|2022Cited by 166
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phaseKomal Srivastava, Temima Yellin, Juan Manuel Carreño et al.|Immunity|2024Cited by 134
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variantsAna S. Gonzalez‐Reiche, Harm van Bakel, Hala Alshammary et al.|Nature Communications|2023Cited by 98
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myelomaAdolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes et al.|Cancer Cell|2021Cited by 76
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patientsAdolfo Aleman, Samir Parekh, Oliver Van Oekelen et al.|Cancer Cell|2022Cited by 38